Who qualifies for the Medicare GLP-1 Bridge?

Short answer: you need an eligible Medicare drug-plan type, the adult weight-management criteria and prior authorization. A GLP-1 paid through Part D in 2026 rules out Bridge access for 2026. The three clinical tiers use starting BMI: 35+, 30+ with specified conditions, or 27+ with specified conditions. Other covered indications use the regular Part D route; a clinical BMI tier alone does not establish full eligibility.

Eligibility summary and plan-type guidance corrected October 6, 2026; CMS sources are linked below.

First requirement: Medicare drug coverage

You must be enrolled in a standalone PDP or an eligible Medicare Advantage coordinated-care drug plan, such as an HMO, HMO-POS or PPO. CMS excludes private fee-for-service, cost, health care prepayment, PACE, fallback and religious fraternal arrangements unless a separate standalone PDP applies. Confirm your exact plan type.

Prior Part D GLP-1 use also matters

A GLP-1 paid by your Part D plan in 2026 rules out Bridge access for 2026, including supplemental coverage for weight management. CMS has not determined the 2027 lookback period. Confirm your claims history rather than relying on BMI alone.

Use BMI at the start of GLP-1 therapy

CMS uses the BMI and qualifying clinical criteria at therapy initiation, even if treatment began before Medicare enrollment or July 2026. A lower BMI after weight loss does not replace your starting BMI. Ask your prescriber for the starting records.

The three eligibility tiers

The three conditions that route you elsewhere

These diagnoses use the standard Part D route under the applicable indication. Check your plan’s formulary, authorization requirements and copay; a diagnosis does not guarantee coverage. Extra Help and out-of-pocket rules apply to covered Part D drugs.

• Type 2 diabetes — GLP-1s like Ozempic and Mounjaro are covered as diabetes treatment.
• Moderate-to-severe obstructive sleep apnea — Zepbound carries an OSA indication. (Mild sleep apnea does not route you out of the Bridge.)
• MASH (noncirrhotic, with moderate-to-advanced liver scarring, F2–F3 fibrosis) — covered under its own indication.

Cardiovascular history: confirm why the drug is prescribed

A prior heart attack, stroke or symptomatic PAD can satisfy a weight-management Bridge criterion. If the GLP-1 prescription is for reducing major cardiovascular-event risk in established cardiovascular disease, it goes to Part D, even when weight management is also intended. History alone is not a blanket Bridge exclusion.

How eligibility is actually decided

Not by you, and not by this site: your prescriber submits a prior authorization to the program’s central processor (administered by Humana) documenting your BMI and any qualifying condition. Our checker mirrors the published criteria so you know what to expect before the appointment.

Take the 2-minute eligibility check →

Deep dives: every tier, condition, and threshold

Ready to move? How to apply, step by step.

Correction, October 6, 2026: earlier summaries and the chart treated drug coverage and a BMI tier as sufficient. Eligible plan type, prior Part D use and the remaining program requirements also apply.

Sources: CMS — Medicare GLP-1 Bridge · CMS provider guidance · AARP